We are live on ! Find out more
NC

Nicholas Company Portfolio holdings

AUM $5.1B
1-Year Est. Return 8.43%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+8.43%
3 Year Est. Return
+54.31%
5 Year Est. Return
+77.46%
10 Year Est. Return
+337.16%
AUM
$4.5B
AUM Growth
+$94.9M
Cap. Flow
-$25.6M
Cap. Flow %
-0.57%
Top 10 Hldgs %
21.03%
Holding
225
New
17
Increased
85
Reduced
77
Closed
10

Top Buys

1
FAST icon
Fastenal
FAST
+$35.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$21M
3
KDP icon
Keurig Dr Pepper
KDP
+$20.3M
4
EFX icon
Equifax
EFX
+$17.3M
5
EWBC icon
East-West Bancorp
EWBC
+$13.4M

Top Sells

1
DVA icon
DaVita
DVA
+$42.1M
2
GWW icon
W.W. Grainger
GWW
+$41.1M
3
ABBV icon
AbbVie
ABBV
+$35.2M
4
SWKS icon
Skyworks Solutions
SWKS
+$25.8M
5
PNRA
Panera Bread Co
PNRA
+$11.9M

Sector Composition

1 Healthcare 21.03%
2 Technology 17.22%
3 Financials 15.03%
4 Industrials 14.79%
5 Consumer Discretionary 13.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BURL icon
201
Burlington
BURL
$22B
$1.86M 0.04%
20,255
-15,740
-44% -$1.51M
CONE
202
DELISTED
CyrusOne Inc Common Stock
CONE
$1.79M 0.04%
+32,085
New +$1.77M
TROW icon
203
T. Rowe Price
TROW
$25.2B
$1.33M 0.03%
18,000
– –
CVX icon
204
Chevron
CVX
$371B
$1.3M 0.03%
12,470
– –
UHS icon
205
Universal Health Services
UHS
$9.16B
$927K 0.02%
7,600
-65,365
-90% -$7.78M
MRSH
206
Marsh
MRSH
$87.3B
$904K 0.02%
11,600
– –
DG icon
207
Dollar General
DG
$27.9B
$699K 0.02%
9,700
-4,900
-34% -$353K
PEP icon
208
PepsiCo
PEP
$188B
$612K 0.01%
5,300
– –
CHRW icon
209
C.H. Robinson
CHRW
$24.3B
$611K 0.01%
8,900
-101,770
-92% -$7.21M
COR
210
DELISTED
Coresite Realty Corporation
COR
$569K 0.01%
+5,500
New +$552K
GWW icon
211
W.W. Grainger
GWW
$66B
$568K 0.01%
3,150
-217,840
-99% -$41.1M
BL icon
212
BlackLine
BL
$1.75B
$290K 0.01%
+8,115
New +$269K
ENLC
213
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$214K ﹤0.01%
12,200
-1,000
-8% -$17.8K
ABBV icon
214
AbbVie
ABBV
$455B
– –
-540,620
Closed -$35.2M
CBU icon
215
Community Bank
CBU
$3.62B
– –
-4,800
Closed -$263K
GNTX icon
216
Gentex
GNTX
$5.2B
– –
-428,380
Closed -$9.14M
JNK icon
217
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.36B
– –
-4,167
Closed -$461K
MCD icon
218
McDonald's
MCD
$192B
– –
-600
Closed -$77K
WPP icon
219
WPP
WPP
$4.09B
– –
-101,640
Closed -$11.1M
WSM icon
220
Williams-Sonoma
WSM
$27B
– –
-6,200
Closed -$166K
ALXN
221
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-50,265
Closed -$6.09M
WSTC
222
DELISTED
West Corporation
WSTC
– –
-19,800
Closed -$483K
PNRA
223
DELISTED
Panera Bread Co
PNRA
– –
-45,280
Closed -$11.9M
5 6 7 8
9

Similar funds

VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CTC
Central Trust Company Jefferson City, Missouri $5.08B AUM 25.65% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Nicholas Company's Q2 2017 Portfolio in Review

As of Q2 2017, Nicholas Company held 225 positions worth $4.5B, up 2.2% from $4.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Company's Q2 2017 filing shows 17 new, 85 increased, 77 reduced and 10 closed positions. Its largest new stake was Keurig Dr Pepper: 216,925 shares worth $19.8M. The largest sale was DaVita, an estimated $42.1M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

  • Nicholas Company's largest Q2 2017 buy was Keurig Dr Pepper: 216,925 shares worth $19.8M.
  • Nicholas Company added most to Fastenal in Q2 2017, an estimated $35.3M increase.
  • Nicholas Company's biggest Q2 2017 reduction was DaVita, cutting an estimated $42.1M.
  • Nicholas Company fully exited AbbVie in Q2 2017, selling an estimated $35.2M.
  • Nicholas Company's ten largest holdings make up 21% of its $4.5B portfolio in Q2 2017.
  • Nicholas Company opened 17 new positions and closed 10 in Q2 2017.
  • Nicholas Company's portfolio value rose 2.2% quarter-over-quarter to $4.5B.

Based on Nicholas Company's 13F filing for Q2 2017, filed 11 Aug 2017.